Prophylaxis, therapy and prevention of viral respiratory infections.
作者信息
Kafetzis Dimitris A
机构信息
University of Athens, Second Department of Pediatrics, "P & A Kyriakou" Children's Hospital, Athens 115 27, Greece.
出版信息
Paediatr Respir Rev. 2004;5 Suppl A:S185-9. doi: 10.1016/s1526-0542(04)90035-8.
Abstract
摘要
相似文献
1
Prophylaxis, therapy and prevention of viral respiratory infections.
Paediatr Respir Rev. 2004;5 Suppl A:S185-9. doi: 10.1016/s1526-0542(04)90035-8.
2
[Respiratory syncytial virus].
Uirusu. 2005 Jun;55(1):77-84. doi: 10.2222/jsv.55.77.
3
18th International Conference on Antiviral Research. Respiratory viruses.
IDrugs. 2005 Jun;8(6):465-6.
4
[Infections with respiratory viruses].
Ther Umsch. 1994 Aug;51(8):563-8.
5
RSV and influenza. Treatment and prevention.
Adv Exp Med Biol. 2004;549:169-75.
6
Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections.
Am Fam Physician. 2003 Feb 15;67(4):763-6, 675.
7
Common (but not always considered) viral infections of the lower respiratory tract.
Pediatr Ann. 1996 Oct;25(10):577-84. doi: 10.3928/0090-4481-19961001-10.
8
Respiratory syncytial virus disease: update on treatment and prevention.
Expert Rev Anti Infect Ther. 2011 Jan;9(1):27-32. doi: 10.1586/eri.10.140.
9
[Expert recommendations for the prevention of common respiratory viral infections in neonates].
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Aug 15;26(8):789-794. doi: 10.7499/j.issn.1008-8830.2405078.
10
Prevention and treatment of viral infections in stem cell transplant recipients.
Br J Haematol. 2002 Jul;118(1):44-57. doi: 10.1046/j.1365-2141.2002.03515.x.
引用本文的文献
1
Enhanced clinical utility of the NucliSens EasyQ RSV A+B Assay for rapid detection of respiratory syncytial virus in clinical samples.
Eur J Clin Microbiol Infect Dis. 2006 Mar;25(3):167-74. doi: 10.1007/S10096-006-0112-4.
本文引用的文献
1
Viral pneumonia in children.
Semin Pediatr Infect Dis. 1998 Jul;9(3):217-233. doi: 10.1016/S1045-1870(98)80035-6. Epub 2006 Jun 3.
2
Severe respiratory syncytial virus infection among otherwise healthy prematurely born infants: What are we trying to prevent?
Paediatr Child Health. 1998 Nov;3(6):402-4. doi: 10.1093/pch/3.6.402.
3
The new nasal spray influenza vaccine.
Pediatr Infect Dis J. 2001 Aug;20(8):731-2. doi: 10.1097/00006454-200108000-00002.
4
The Japanese experience with vaccinating schoolchildren against influenza.
N Engl J Med. 2001 Mar 22;344(12):889-96. doi: 10.1056/NEJM200103223441204.
5
Burden of disease--implications for future research.
JAMA. 2001 Feb 7;285(5):535-9. doi: 10.1001/jama.285.5.535.
6
Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season. The Palivizumab Outcomes Study Group.
Pediatr Infect Dis J. 2000 Nov;19(11):1068-71. doi: 10.1097/00006454-200011000-00007.
7
Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.
Pediatr Infect Dis J. 2000 Jul;19(7):592-7. doi: 10.1097/00006454-200007000-00002.
8
Bronchiolitis-associated hospitalizations among US children, 1980-1996.
JAMA. 1999 Oct 20;282(15):1440-6. doi: 10.1001/jama.282.15.1440.
9
10
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus.
J Infect Dis. 1997 Nov;176(5):1215-24. doi: 10.1086/514115.
Zotero 插件